Insulin degludec is a new ultra-long-acting insulin analogue
Achieving optimal glycemic control is an important aspect of preventing and slowing the progression of diabetes-associated complications, and reducing the cost of their treatment. Long-acting insulin analogues, glargine and detemir, provide better metabolic control with reduced risk of hypoglycaemia...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN RU |
| Publié: |
Endocrinology Research Centre
2014
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/6e417b1bfcf04a568b284fe7ce6e9f5f |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|